Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9bn in strategic expansion

In a major development in the biotechnology industry, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN) have announced a definitive agreement ... Read More